Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy

This publication has 174 references indexed in Scilit:

• Retracted: RNAi‐mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease‐9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth
  International Journal of Cancer, 2007
• Hypoxia: A key regulator of angiogenesis in cancer
  Cancer and Metastasis Reviews, 2007
• The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition
  Proceedings of the National Academy of Sciences, 2006
• Specificity in reactive oxidant signaling: think globally, act locally
  The Journal of cell biology, 2006
• Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells
  Free Radical Biology & Medicine, 2006
• RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo
  Journal of Biological Chemistry, 2005
• Involvement of PI3K and MAPK Signaling in bcl-2-induced Vascular Endothelial Growth Factor Expression in Melanoma Cells
  Molecular Biology of the Cell, 2005
• Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-inducible Factor 1α, HDM2, and p70S6K1 in Response to Phosphatidylinositol 3-Kinase/AKT Signaling
  Journal of Biological Chemistry, 2004
• TNFα Activates c-Jun Amino Terminal Kinase through p47phox
  Experimental Cell Research, 2002
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971